Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Pam Gore Receives Beverley Boesch Legacy Award
Pot Policies in Workers' Compensation and Auto Casualty [Webinar]
Even as the pandemic takes center stage, marijuana legislation has been makin
Staying Connected During COVID-19
We asked our Field Case Managers how they were staying connected to their injured workers and finding meaning and purpose during the COVID-19 pandemic. Their responses were more than we expected. It warmed our hearts and we were happy to gain a small insight into their lives. We’d like to share their moving and heartfelt video messages with you in a special installment of The Sounding Board blog.
Potential Drug Therapy Treatments for COVID-19: Impact on Workers’ Compensation
As response to the COVID-19 pandemic shifts into new phases—parts of the United States are reopening and businesses and many states are considering how to get people back to work—scientists continue to research potential medications that could be used to treat the disease.
COVID-19 Drug Therapy Treatments: Potential Impact on Workers' Comp
As researchers continue to look into potential treatments for COVID-19, how could the workers' compensation industry be affected?
Coronavirus Resources from SEMA and PRI
The Specialty Equipment Market Association (SEMA) and Performance Racing Industry (PRI) provide a consolidated, state-by-state list of COVID-19 industry information and guidance.